Valuation: Jianmin Pharmaceutical Group Co.,Ltd.

Market Cap 4.21B 621M 546M 508M 466M 875M 59.84B 889M 6.03B 2.35B 29.42B 2.33B 2.28B 102B P/E 2024
17.5x
P/E 2025 14.2x
Enterprise Value 3.13B 462M 406M 377M 346M 651M 44.5B 661M 4.48B 1.75B 21.88B 1.73B 1.7B 75.65B EV / Sales 2024
1.56x
EV / Sales 2025 1.21x
Free-Float
65.13%
Yield 2024
2.16%
Yield 2025 2.68%
1 day-4.76%
1 week-6.76%
Current month+10.12%
1 month+5.95%
3 months-16.88%
6 months-23.40%
Current year-18.29%
1 week 27.42
Extreme 27.42
29.97
1 month 24.68
Extreme 24.68
30.9
Current year 24.68
Extreme 24.68
35.87
1 year 24.68
Extreme 24.68
43.72
3 years 24.68
Extreme 24.68
74.56
5 years 24.68
Extreme 24.68
86.78
10 years 13.69
Extreme 13.69
86.78
Manager TitleAgeSince
President 50 2020-09-08
Director of Finance/CFO 54 2018-01-01
Compliance Officer 38 -
Director TitleAgeSince
Director/Board Member 64 -
Chairman 58 2025-07-29
Chairman 39 2019-09-16
Date Insider Type Main position Quantity % Market Cap.
12/13/21 Sell

Chairman

5,000 0.0033%
Change 5-day change 1-year change 3-year change Capi.($)
-4.76%-6.76%-32.64%-61.74% 621M
+0.86%+1.43%+47.17%+163.68% 1,067B
+1.59%+4.09%+56.51%+52.50% 635B
+0.95%+1.91%+36.30%+82.78% 458B
+1.60%+6.25%+37.00%+31.03% 347B
-0.60%+1.52%+36.67%+41.41% 295B
-0.14%+0.60%+17.29%+18.74% 262B
+0.09%-2.82%-29.09%-39.57% 216B
+1.22%+2.66%+22.66%+59.87% 203B
-1.18%-3.70%+11.28%+67.52% 161B
Average -0.04%+0.55%+20.32%+41.62% 364.41B
Weighted average by Cap. +0.76%+1.95%+35.98%+79.07%

Financials

2024 2025
Net sales 3.5B 518M 455M 423M 388M 729M 49.85B 740M 5.02B 1.96B 24.51B 1.94B 1.9B 84.74B 3.37B 498M 437M 407M 373M 701M 47.93B 712M 4.83B 1.89B 23.56B 1.87B 1.83B 81.47B
Net income 362M 53.49M 46.98M 43.69M 40.09M 75.33M 5.15B 76.49M 519M 203M 2.53B 201M 196M 8.76B 360M 53.14M 46.68M 43.41M 39.83M 74.84M 5.12B 76M 515M 201M 2.52B 200M 195M 8.7B
Net Debt -942M -139M -122M -114M -104M -196M -13.39B -199M -1.35B -527M -6.58B -522M -511M -22.77B -1.08B -159M -140M -130M -119M -224M -15.34B -228M -1.55B -604M -7.54B -598M -585M -26.08B
Logo Jianmin Pharmaceutical Group Co.,Ltd.
Jianmin Pharmaceutical Group Co Ltd, formerly Wuhan Jianmin Pharmaceutical Groups Co Ltd, is a China-based company principally engaged in the research and development, manufacturing, wholesale and retail of pharmaceuticals. The Company operates its businesses through two segments. The Pharmaceutical Production and Sales segment is primarily engaged in the production of various types of Chinese patent medicines and sales to pharmaceutical distributors at all levels, including sales to the commercial division within the group that sells to non-hospitals. The Commercial segment is primarily engaged in the purchase of drugs from manufacturers and manufacturers' agents, and then distribution to lower-level distributors, sales to hospitals and retail sales in pharmacies. The Company mainly operates its businesses in the domestic market.
Employees
2,257
Date Price Change Volume
26-07-24 CN¥27.43 -4.76% 2,541,300
26-07-23 CN¥28.80 -0.96% 2,521,900
26-07-22 CN¥29.08 +1.82% 4,089,134
26-07-21 CN¥28.56 -2.56% 4,474,100
26-07-20 CN¥29.31 -0.37% 3,991,841

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 600976 Stock